Kalshi Launches Platform for Bets on Biotech Trials, Drug Approvals
2026-07-16 12:01:15
Kalshi Inc. is expanding into biotechnology with a platform for wagers on the outcomes of clinical trials and regulatory decisions, giving traders a more direct way to bet on key industry catalysts, according to Bloomberg.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Next article：
ARK研究主管反驳a16z Crypto
